Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Eastman

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasisFrederick S Buckner, Richard T Eastman, Kohei Yokoyama, et al.
Journal of Lipid Research|December 13, 2005
Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylationRichard T Eastman, Frederick S Buckner, Kohei Yokoyama, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
The Candida albicans lanosterol 14-alpha-demethylase (ERG11) gene promoter is maximally induced after prolonged growth with antifungal drugsJia L Song, Jo Beth Harry, Richard T Eastman, et al.
Nature|November 8, 1979
Renal conservation of antifreeze peptide in Antarctic eelpout, Rhigophila dearborniJ T Eastman, A L De Vries, R E Coalson, et al.
Chembiochem : a European Journal of Chemical Biology|November 18, 2017
New WS9326A Derivatives and One New Annimycin Derivative with Antimalarial Activity are Produced by Streptomyces asterosporus DSM 41452 and Its MutantSongya Zhang, Jing Zhu, David L Zechel, et al.
Frontiers in Pharmacology|October 19, 2018
Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel StructuresDaniel J Mason, Richard T Eastman, Richard P I Lewis, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|February 2, 2008
Abdominal mucinous cystic neoplasm in a male childJean J Luo, Fabien K Baksh, John D Pfeifer, et al.
ACS Central Science|June 3, 2020
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19Richard T Eastman, Jacob S Roth, Kyle R Brimacombe, et al.
ACS Pharmacology & Translational Science|December 17, 2020
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity AssayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasisFrederick S Buckner, Richard T Eastman, Kohei Yokoyama, et al.
Journal of Lipid Research|December 13, 2005
Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylationRichard T Eastman, Frederick S Buckner, Kohei Yokoyama, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
The Candida albicans lanosterol 14-alpha-demethylase (ERG11) gene promoter is maximally induced after prolonged growth with antifungal drugsJia L Song, Jo Beth Harry, Richard T Eastman, et al.
Nature|November 8, 1979
Renal conservation of antifreeze peptide in Antarctic eelpout, Rhigophila dearborniJ T Eastman, A L De Vries, R E Coalson, et al.
Chembiochem : a European Journal of Chemical Biology|November 18, 2017
New WS9326A Derivatives and One New Annimycin Derivative with Antimalarial Activity are Produced by Streptomyces asterosporus DSM 41452 and Its MutantSongya Zhang, Jing Zhu, David L Zechel, et al.
Frontiers in Pharmacology|October 19, 2018
Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel StructuresDaniel J Mason, Richard T Eastman, Richard P I Lewis, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|February 2, 2008
Abdominal mucinous cystic neoplasm in a male childJean J Luo, Fabien K Baksh, John D Pfeifer, et al.
ACS Central Science|June 3, 2020
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19Richard T Eastman, Jacob S Roth, Kyle R Brimacombe, et al.
ACS Pharmacology & Translational Science|December 17, 2020
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity AssayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
Pageof 11